Clinical Trial Update: A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing odronextamab plus chemotherapy with rituximab plus chemotherapy in adults with previously untreated diffuse large B-cell lymphoma; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Odronextamab (odronextamab)
• Rituximab (rituximab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Diffuse Large B-cell Lymphoma (DLBCL) | Phase 3 | Status: ACTIVE_NOT_RECRUITING